Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Autologous Stem Cell Transplantation Followed by Nonmyeloablative Allogeneic Stem Cell Transplantation for Patients With Relapsed or Refractory Lymphoma - A Multi-center Trial

NCT00005803 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT00005803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Autologous Stem Cell Transplantation Followed by Nonmyeloablative Allogeneic Stem Cell Transplantation for Patients With Relapsed or Refractory Lymphoma - A Multi-center Trial
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 1999
Completion date
October 31, 2018
Enrollment
76 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

prolymphocytic leukemia, recurrent adult hodgkin lymphoma, recurrent childhood hodgkin lymphoma, recurrent childhood non-hodgkin lymphoma, recurrent chronic lymphocytic leukemia, recurrent non-hodgkin lymphoma, recurrent small lymphocytic lymphoma, refractory childhood hodgkin lymphoma, refractory chronic lymphocytic leukemia, refractory hodgkin lymphoma, refractory non-hodgkin lymphoma, refractory small lymphocytic lymphoma, t-cell chronic lymphocytic leukemia, t-cell prolymphocytic leukemia